222 related articles for article (PubMed ID: 17701193)
1. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
Horn LC; Purz S; Krumpe C; Bilek K
Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu expression in Paget disease of the vulva and the female breast.
Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast.
Ellis PE; Wong Te Fong LF; Rolfe KJ; Crow JC; Reid WM; Davidson T; MacLean AB; Perret CW
Anticancer Res; 2002; 22(2A):857-61. PubMed ID: 12014662
[TBL] [Abstract][Full Text] [Related]
4. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
Meissner K; Rivière A; Haupt G; Löning T
Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
[TBL] [Abstract][Full Text] [Related]
5. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
Bianco MK; Vasef MA
Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
Liegl B; Horn LC; Moinfar F
Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
[TBL] [Abstract][Full Text] [Related]
7. [Associated Paget's disease of the vulva and of the nipple in the same patient: pathology with ultrastructural study (author's transl)].
Fetissoff F; Arbeille-Brassart B; Lansac J; Sam-Giao M; Granger M; Lorette G
Ann Dermatol Venereol; 1982; 109(1):43-50. PubMed ID: 6280570
[TBL] [Abstract][Full Text] [Related]
8. Vulvar and breast Paget's disease with synchronous underlying cancer: a unique association.
Spiliopoulos D; Spiliopoulos M; Dandolu V; Mastrogiannis D
Arch Gynecol Obstet; 2009 Aug; 280(2):313-5. PubMed ID: 19112575
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease.
Wolber RA; Dupuis BA; Wick MR
Am J Clin Pathol; 1991 Aug; 96(2):243-7. PubMed ID: 1713741
[TBL] [Abstract][Full Text] [Related]
10. Synchronous Paget's disease of the vulva and breast.
Popiolek DA; Hajdu SI; Gal D
Gynecol Oncol; 1998 Oct; 71(1):137-40. PubMed ID: 9784335
[TBL] [Abstract][Full Text] [Related]
11. [Expression status of HER2 in mammary and extramammary Paget's disease].
Meng H; Zheng XY; Zhang L; Li WC
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
[No Abstract] [Full Text] [Related]
12. [Paget's disease of the vulva associated with Paget's disease of the breast. Apropos of a case report. Review of the literature].
Body G; Granger M; Fetissoff F; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1982; 11(7):815-21. PubMed ID: 6298303
[TBL] [Abstract][Full Text] [Related]
13. Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast.
Ellis PE; Cano SD; Fear M; Kelsell DP; Ghali L; Crow JC; Perrett CW; MacLean AB
Mod Pathol; 2008 Oct; 21(10):1192-9. PubMed ID: 18469796
[TBL] [Abstract][Full Text] [Related]
14. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
[TBL] [Abstract][Full Text] [Related]
15. Claudin expression in breast tumors.
Kulka J; Tökés AM
Hum Pathol; 2005 Jul; 36(7):859; author reply 860. PubMed ID: 16084960
[No Abstract] [Full Text] [Related]
16. HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study.
Sek P; Zawrocki A; Biernat W; Piekarski JH
Histopathology; 2010 Oct; 57(4):564-71. PubMed ID: 20955381
[TBL] [Abstract][Full Text] [Related]
17. The routine immunohistochemical evaluation in Paget disease of the nipple.
Marczyk E; Kruczak A; Ambicka A; Mularz K; Harazin-Lechowska A; Moskal J; Sokołowski A; Mituś J; Ryś J
Pol J Pathol; 2011 Dec; 62(4):229-35. PubMed ID: 22246908
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
Karam A; Berek JS; Stenson A; Rao J; Dorigo O
Gynecol Oncol; 2008 Dec; 111(3):568-71. PubMed ID: 18252264
[TBL] [Abstract][Full Text] [Related]
19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
